Serum markers of type iii and iv procollagen processing predict recurrence of fibrosis in liver transplanted patients

HIGHLIGHTS

  • who: Mette Juul Nielsen and collaborators from the University Medical have published the research work: Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients, in the Journal: Scientific Reports Scientific Reports of 30/09/2019
  • what: With this study, the authors showed that patients with high type IV collagen turnover after LT had a up to 85-fold increased risk of RC compared to patients with low levels. This study is intended to provide the first proof-of-concept that these markers are indeed reflecting the dynamics . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?